THe hype of unvalidated testing22 Oct 2021 15:49
To be fair to ODX, they can not be blamed for whipping up a lather or hyping up expectation building up to today's big gov "laise faire" lft website. No, that was entirely down to the usual suspects here and twitter, when there really was no indication that there would be an immediate benefit to ODX. ODX would have announced a UK distribution deal if their tests were going to be sold by retailers.
However, I'm wondering where all the chat about the great pending antibody sales went to, which was driven by ODX communications, in fact no less than CK himself who said in mid July:-
""In terms of near term demand there are probably 3 countries where we are just waiting on final registrations to go through, once they're complete, there is the expectation that the demand will come and it will be significant demand as well from these countries from what we have been led to believe. And hence why keiran alluded to in terms of those covid reviews for rtc early on in the presentation, 60% obviously went to the gov but there was 40% that has been manufactured, and we have obviously continued to manufacture in quarter 1 that we've sold to abingdon and there is expectation that those tests will be used in the very near term."
"used in the very near term".
A month after that, Abingdon put out via an RNS "The Company has not seen significant commercial traction with the AbC-19(TM) product to date but remains encouraged by the ongoing discussions in various overseas territories..."
And here we are, staring into November, a full 3 months after that "used in the very near term", and not so much as an announcement of even one of those countries completing "final registration" never mind the signing of a sales deal.
Its these constant, constant failed timelines that sow doubt into anything the company says. Here we are, less than 50 shopping days before christmas, AND NOT A SINGLE ANNOUNCED COVID LFT PURCHASE ORDER IN ALL OF 2021.